Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
26 June 2024
| m 01:43 | Ibrutinib (Imbruvica) diffhist +1 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" | ||||
| m 01:43 | Obinutuzumab (Gazyva) diffhist +1 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" | ||||
21 June 2024
| m 23:48 | Bevacizumab-adcd (Vegzelga) diffhist +10 Jwarner talk contribs →Also known as | ||||
| m 23:47 | Bevacizumab-maly (Alymsys) diffhist +9 Jwarner talk contribs →Also known as | ||||
| N 23:42 | Bevacizumab-tnjn (Avzivi) diffhist +4,211 Jwarner talk contribs Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Bevacizumab (Avastin) page, except for the details of FDA indication and the refe..." | ||||
18 June 2024
| m 00:12 | Lisocabtagene maraleucel (Breyanzi) diffhist 0 Jwarner talk contribs →History of changes in FDA indication | ||||
1 June 2024
| m 03:43 | Cytarabine (Ara-C) diffhist +156 Jwarner talk contribs →History of changes in PMDA indication | ||||
| m 03:31 | Lisocabtagene maraleucel (Breyanzi) diffhist +340 Jwarner talk contribs | ||||
28 May 2024
| m 20:53 | Rituximab-arrx (Riabni) diffhist +25 Jwarner talk contribs →Also known as | ||||